REACH/Galleri-Medicare Study
This multi-center comparative, prospective, cohort study is designed to assess the real world clinical impact, including safety and test performance, of the Galleri® test.
View Study
PATHFINDER 2 Study
This is a prospective, multi-center interventional study of the Galleri® multi-cancer early detection test with return of test results for participants enrolled through healthcare systems in North America.
View Study
REFLECTION Study
An observational study of patients who have been administered the Galleri® test.
View Study
NHS-Galleri Trial
A prospective, randomized, controlled trial to assess the performance and clinical utility of the Galleri® test for population screening in the UK when added to standard of care.
View Study
SUMMIT Study
A prospective, observational, longitudinal, cohort study in London, United Kingdom. The study is designed to enroll approximately 13,000 men and women who do not have a high risk for lung or other cancer due to significant smoking history at the time of enrollment.
View Study
STRIVE Study
A prospective, observational, longitudinal, cohort study that enrolled approximately 100,000 women to refine the predictive ability of the Galleri® test to detect invasive cancers.
View Study
The Circulating Cell-free Genome Atlas (CCGA) Study
A multicenter, prospective, case-control, observational, longitudinal study designed to identify the best performing assay and then determine whether genome-wide cfDNA methylation sequencing in combination with machine learning could distinguish cancer from non-cancer and localize a signal shared by a large number of cancers.
View Study
PATHFINDER Study
A prospective, interventional, return-of-results, multi-center study to assess the implementation of an earlier version of the Galleri® multi-cancer early detection (MCED) test in a clinical setting. Later, blood samples were reanalyzed with the current version of Galleri.
View Study
